Credential Securities’s AstraZeneca AZN Stock Holding History

Credential Securities’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	$753K	Sell	10,719 -698	-6%	-$50.2K	0.17%	89
2018 Q1	$799K	Sell	11,417 -182	-2%	-$12.6K	0.19%	85
2017 Q4	$805K	Sell	11,599 -152	-1%	-$10.3K	0.19%	93
2017 Q3	$796K	Buy	11,751 +123	+1%	+$7.77K	0.21%	91
2017 Q2	$793K	Sell	11,628 -227	-2%	-$14.8K	0.24%	87
2017 Q1	$739K	Sell	11,855 -284	-2%	-$16.5K	0.26%	88
2016 Q4	$664K	Sell	12,139 -358	-3%	-$20.3K	0.26%	93
2016 Q3	$821K	Buy	12,497 +10	+0.1%	+$654	0.37%	81
2016 Q2	$754K	Buy	12,487 +12	+0.1%	+$697	0.39%	83
2016 Q1	$703K	Sell	12,475 -37	-0.3%	-$2.22K	0.41%	76
2015 Q4	$849K	Buy	12,512 +254	+2%	+$16.7K	0.56%	55
2015 Q3	$780K	Sell	12,258 -67	-0.5%	-$4.41K	0.54%	57
2015 Q2	$785K	Buy	12,325 +233	+2%	+$16K	0.5%	61
2015 Q1	$827K	Buy	12,092 +732	+6%	+$50.9K	0.54%	50
2014 Q4	$800K	Buy	11,360 +365	+3%	+$26.1K	0.52%	52
2014 Q3	$791K	Buy	10,995 +743	+7%	+$54.4K	0.53%	48
2014 Q2	$762K	Buy	10,252 +870	+9%	+$62.9K	0.5%	54
2014 Q1	$609K	Buy	+9,382	New	+$606K	0.45%	55

Other funds holding AZN

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Credential Securities's AZN Position: Q2 2018 in Review

Credential Securities reduced its AstraZeneca (AZN) stake by 6.1% in Q2 2018, selling an estimated $50.2K and leaving 10,719 shares worth $753K. The position accounts for 0.17% of the portfolio, ranked #89.

Credential Securities first reported a position in AZN in Q1 2014 and has held it in 18 quarters since. The position peaked at $849K in Q4 2015. 531 funds tracked by Wall St. Rank hold AZN as of Q2 2018.

Credential Securities held 10,719 shares of AstraZeneca worth $753K as of Q2 2018.
Credential Securities sold 698 AstraZeneca shares in Q2 2018, an estimated $50.2K.
AstraZeneca made up 0.17% of Credential Securities's portfolio in Q2 2018, its #89 holding.
Credential Securities first reported a position in AstraZeneca in Q1 2014 and has held it in 18 quarters since.
Credential Securities's AstraZeneca position peaked at $849K in Q4 2015.
531 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2018.

Based on Credential Securities's 13F filing for Q2 2018, filed 21 Jul 2025.